In this first of a series of four sets of Homerun Slides, we review the basics of SGLT-2 inhibitors incuding Mode of Action, and Efficacy. and then look at how Canagliflozin has worked in poorly controlled type 2 diabetes patients…. To download the complete set in PowerPoint (.ppt) format, just …
Read More »Stanley Schwartz, MD: Classifying Diabetes Types, ADA 2014, Part 3
In this week’s Homerun Slides, Dr. Stanley Schwartz continues his exploration of a beta-cell centric classification model for diabetes and includes a detailed diagram explanation featuring the Egregious Eleven….
Read More »Handbook of Diabetes, 4th Edition, Excerpt #7: Other Types of Diabetes
Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP Maturity-onset diabetes of the young Maturity-onset diabetes of the young (MODY) owes its name to a time when diabetes was defined by age of onset. The nomenclature has stuck, however, and MODY defines usually non-insulin dependent diabetes occurring before the age …
Read More »PreDiabetes Screening Test
PreDiabetes Screening Test Finally there’s a test that only focuses on PreDiabetes. At the recent AADE meeting, a new company came our way with a home laboratory test that can demonstrate whether a patient has prediabetes or even diabetes. It’s a mail-away finger-stick test that is 99.9% accurate. Now you can …
Read More »FDA Approves J&J’s Invokamet Combo (SGLT-2 + Metformin)
The US Food and Drug Administration has approved Invokamet, a fixed-dose therapy combining Invokana (canagliflozin) and metformin…. Invokana, a member of the new class of drugs known as sodium glucose co-transporter 2 (SGLT2) inhibitors, was approved in the USA as a single agent in March 2013. The thumbs-up is based …
Read More »Should Non-diabetics Use Diabetes Drugs?
A study involving over 180,000 people showed that patients treated with metformin can live longer than non-diabetics….
Read More »The Importance of Control Solution
Control solution, used for ensuring the proper function of glucose meters, doesn’t appear to be a priority among physicians, pharmacists, or patients….
Read More »Early Insulin Delays Diabetes But Are There Negative Consequences?
One researcher comments, "Please don’t fall into this trap that you can prevent diabetes with insulin."…
Read More »Effects of Intensive Glycemic Control on Ischemic Heart Disease
How can three landmark trials of intensive vs standard glucose-lowering strategies — ADVANCE, ACCORD, and VADT — raise more questions than they answer?…
Read More »Peripheral Neuropathy Associated with CV Disease and Stroke in Type 2 Diabetes Patients
Testing for peripheral neuropathy may provide a way to identify individuals at higher risk of cardiovascular events….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.